CONMED Corporation Announces First Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/10/2026
- S&P 500 ends down as oil tops $100 per barrel
- Trump promises $5,000 payout to U.S. adults if Republicans win election
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Rogers adds Sportsnet+ content to Xfinity TV packages for free
- AeroVironment (AVAV) Tops Q1 EPS by 29c, Offers Guidance
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
CONMED (CNMD) PT Raised to $73 at Needham & Company
April 26, 2018 6:54 AM EDTNeedham & Company raised its price target on CONMED (NASDAQ: CNMD) to $73.00 (from $71.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "CNMD's 1Q18 revenue and EPS beat consensus and management raised its 2018 revenue and EPS guidance. Revenue growth slowed somewhat to 6.8% CC... More
Conmed (CNMD) Tops Q1 EPS by 9c; Raises Outlook
April 25, 2018 4:15 PM EDTConmed (NASDAQ: CNMD) reported Q1 EPS of $0.53, $0.09 better than the analyst estimate of $0.44. Revenue for the quarter came in at $202.1 million versus the consensus estimate of $196.4 million.
GUIDANCE:
Conmed raises FY2018 EPS to $2.15-$2.20, versus the consensus of $2.14.
For earnings history and earnings-related data on Conmed (CNMD) click here.
... More
